IMMUNOLOGY QUALITY ASSESSMENT PROGRAM

免疫学质量评估计划

• 批准号: 8936676
• 负责人: Thomas Denny
• 金额: $ 137.9万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-30 至 2015-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8936676
• 关键词: CD8B1 gene; Developing Countries; Ensure; Freezing; Immunologic Tests; Immunology; Laboratories; Laboratory Procedures; Libraries; Measures; Online Systems; Performance; Peripheral Blood Mononuclear Cell; Procedures; Records; Reporting; Resolution; Resources; Site; Specific qualifier value; Technology; Testing; Training; base; cost; instrument; novel; programs; repository; CD8B1 gene; Developing Countries; Ensure; Freezing; Immunologic Tests; Immunology; Laboratories; Laboratory Procedures; Libraries; Measures; Online Systems; Performance; Peripheral Blood Mononuclear Cell; Procedures; Records; Reporting; Resolution; Resources; Site; Specific qualifier value; Technology; Testing; Training; base; cost; instrument; novel; programs; repository

The DAIDS Immunology Quality Assessment Program (IQA) provides a critically needed resource that (1) evaluates the abilities of laboratories in the U.S. and in developing countries to accurately and reliably perform study-specified immunological tests (mainly CD4 and CD8 enumeration) and PBMC viable freezing, (2) advises and trains when deficiencies are identified, and (3) evaluates immunology-based technologies for implementation in multi-site DAIDS trials.

WAIDS免疫学质量评估计划（IQA）提供了一种至关重要的资源，（1）评估美国和发展中国家在实验室的能力，以准确，可靠地执行研究指定的免疫学测试（主要是CD4和CD8枚举），并在识别方面进行鉴定时（2），（2）在识别范围内进行识别，（2）在多站点的waeds试验中实施。